US Bancorp’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,313
| Closed | -$112K | – | 3924 |
|
|
2019
Q4 | $112K | Buy |
1,313
+163
| +14% | +$10.9K | ﹤0.01% | 2118 |
|
|
2019
Q3 | $57K | Sell |
1,150
-2,021
| -64% | -$80.6K | ﹤0.01% | 2404 |
|
|
2019
Q2 | $116K | Sell |
3,171
-1,347
| -30% | -$44K | ﹤0.01% | 2132 |
|
|
2019
Q1 | $126K | Sell |
4,518
-370
| -8% | -$8.72K | ﹤0.01% | 2070 |
|
|
2018
Q4 | $93K | Buy |
4,888
+2,016
| +70% | +$46.9K | ﹤0.01% | 2164 |
|
|
2018
Q3 | $86K | Sell |
2,872
-109
| -4% | -$4.11K | ﹤0.01% | 2308 |
|
|
2018
Q2 | $109K | Buy |
2,981
+67
| +2% | +$2.18K | ﹤0.01% | 2198 |
|
|
2018
Q1 | $96K | Sell |
2,914
-331
| -10% | -$10.3K | ﹤0.01% | 2267 |
|
|
2017
Q4 | $89K | Buy |
3,245
+12
| +0.4% | +$370 | ﹤0.01% | 2318 |
|
|
2017
Q3 | $120K | Buy |
3,233
+33
| +1% | +$1.22K | ﹤0.01% | 2138 |
|
|
2017
Q2 | $122K | Sell |
3,200
-213
| -6% | -$9.49K | ﹤0.01% | 2099 |
|
|
2017
Q1 | $167K | Buy |
3,413
+58
| +2% | +$2.65K | ﹤0.01% | 1903 |
|
|
2016
Q4 | $114K | Sell |
3,355
-26,937
| -89% | -$955K | ﹤0.01% | 2059 |
|
|
2016
Q3 | $1.14M | Buy |
30,292
+670
| +2% | +$25.3K | ﹤0.01% | 956 |
|
|
2016
Q2 | $996K | Buy |
29,622
+5,723
| +24% | +$202K | ﹤0.01% | 1009 |
|
|
2016
Q1 | $759K | Sell |
23,899
-4,785
| -17% | -$156K | ﹤0.01% | 1120 |
|
|
2015
Q4 | $1.07M | Buy |
28,684
+4,794
| +20% | +$181K | ﹤0.01% | 922 |
|
|
2015
Q3 | $907K | Buy |
23,890
+21,571
| +930% | +$757K | ﹤0.01% | 1015 |
|
|
2015
Q2 | $66K | Hold |
2,319
| – | – | ﹤0.01% | 2387 |
|
|
2015
Q1 | $65K | Sell |
2,319
-399
| -15% | -$11.2K | ﹤0.01% | 2407 |
|
|
2014
Q4 | $75K | Buy |
+2,718
| New | +$67.3K | ﹤0.01% | 2323 |
|
|
2014
Q3 | – | Sell |
-140
| Closed | -$4K | – | 3606 |
|
|
2014
Q2 | $4K | Sell |
140
-1,177
| -89% | -$31.4K | ﹤0.01% | 3287 |
|
|
2014
Q1 | $37K | Sell |
1,317
-605
| -31% | -$20K | ﹤0.01% | 2608 |
|
|
2013
Q4 | $75K | Buy |
+1,922
| New | +$68.7K | ﹤0.01% | 2247 |
|
Other funds holding MDCO
US Bancorp's MDCO Position: Q1 2020 in Review
US Bancorp sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,313 shares — an estimated $112K sold.
US Bancorp first reported a position in MDCO in Q4 2013 and held it in 24 quarters. The position peaked at $1.14M in Q3 2016. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- US Bancorp reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- US Bancorp sold 1,313 Medicines Co shares in Q1 2020, an estimated $112K.
- US Bancorp first reported a position in Medicines Co in Q4 2013 and held it in 24 quarters.
- US Bancorp's Medicines Co position peaked at $1.14M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.